Matinas BioPharma Holdings, Inc. - Rasio total nilai perusahaan marang pendapatan MTNB

Matinas BioPharma Holdings, Inc. (MTNB) - logo korporat

Patents for LNC technology and strict FDA oversight create a high barrier to entry for competitors for Matinas BioPharma (MTNB). The drug delivery expert team is retained through cutting-edge research and comprehensive benefits packages. The innovative platform converts injections into tablets, simplifying the treatment of infections. The price-to-sales multiple trend clearly demonstrates this potential, and 0.00 reflects the latest level of the metric.

MTNB Matinas BioPharma Holdings: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Matinas BioPharma - rincian analitis lan metrik utama (MTNB)

- rega saham lan prakiraan rega para ahli:
Produk asil prodhuksi Matinas BioPharma Holdings Inc.

The EV/Sales ratio is used for an objective valuation of Matinas BioPharma (MTNB), correlating the total enterprise value, including net debt, with the volume of generated revenue. By analyzing the EV/Sales historical trend, an investor can gauge market expectations for the commercialization of Matinas BioPharma nanocochleates, assessing how effectively the transition to oral drug formulations is being capitalized into the company's valuation relative to its current sales.

Analisis pesaing Matinas BioPharma

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - Multiplikator EV/Sales|GUTS: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Pluristem Therapeutics PLUR|SYBX: Rasio nilai perusahaan marang pendapatan|lipocine.com - Multiplikator EV/Sales|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)